We highlight the crosstalk between GPX1-ROS - AKT cascade bioactivities and cisplatin resistance in NSCLC cells, specifically targeting cisplatin resistance due to aberrant expression of GPX1. Here, GPX1 is linked to non-small cell lung carcinoma.